Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 3
1981 3
1982 6
1983 3
1984 5
1985 9
1986 15
1987 14
1988 13
1989 24
1990 31
1991 25
1992 30
1993 40
1994 34
1995 66
1996 76
1997 107
1998 108
1999 122
2000 139
2001 180
2002 197
2003 250
2004 327
2005 425
2006 486
2007 571
2008 628
2009 756
2010 826
2011 948
2012 1062
2013 1257
2014 1418
2015 1587
2016 1720
2017 1885
2018 2173
2019 2484
2020 3083
2021 3496
2022 4104
2023 4029
2024 3627
2025 3

Text availability

Article attribute

Article type

Publication date

Search Results

34,525 results

Results by year

Filters applied: . Clear all
Page 1
Comprehensive functional genomic resource and integrative model for the human brain.
Wang D, Liu S, Warrell J, Won H, Shi X, Navarro FCP, Clarke D, Gu M, Emani P, Yang YT, Xu M, Gandal MJ, Lou S, Zhang J, Park JJ, Yan C, Rhie SK, Manakongtreecheep K, Zhou H, Nathan A, Peters M, Mattei E, Fitzgerald D, Brunetti T, Moore J, Jiang Y, Girdhar K, Hoffman GE, Kalayci S, Gümüş ZH, Crawford GE; PsychENCODE Consortium; Roussos P, Akbarian S, Jaffe AE, White KP, Weng Z, Sestan N, Geschwind DH, Knowles JA, Gerstein MB. Wang D, et al. Among authors: zhou h. Science. 2018 Dec 14;362(6420):eaat8464. doi: 10.1126/science.aat8464. Science. 2018. PMID: 30545857 Free PMC article.
Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT anti-PD-1-11).
Yang Y, Wang Z, Fang J, Yu Q, Han B, Cang S, Chen G, Mei X, Yang Z, Ma R, Bi M, Ren X, Zhou J, Li B, Song Y, Feng J, Li J, He Z, Zhou R, Li W, Lu Y, Wang Y, Wang L, Yang N, Zhang Y, Yu Z, Zhao Y, Xie C, Cheng Y, Zhou H, Wang S, Zhu D, Zhang W, Zhang L. Yang Y, et al. Among authors: zhou h. J Thorac Oncol. 2020 Oct;15(10):1636-1646. doi: 10.1016/j.jtho.2020.07.014. Epub 2020 Aug 8. J Thorac Oncol. 2020. PMID: 32781263 Free article. Clinical Trial.
CRISPR-based metabolic pathway engineering.
Zhao D, Zhu X, Zhou H, Sun N, Wang T, Bi C, Zhang X. Zhao D, et al. Among authors: zhou h. Metab Eng. 2021 Jan;63:148-159. doi: 10.1016/j.ymben.2020.10.004. Epub 2020 Nov 2. Metab Eng. 2021. PMID: 33152516 Review.
Exploring treatment options in cancer: Tumor treatment strategies.
Liu B, Zhou H, Tan L, Siu KTH, Guan XY. Liu B, et al. Among authors: zhou h. Signal Transduct Target Ther. 2024 Jul 17;9(1):175. doi: 10.1038/s41392-024-01856-7. Signal Transduct Target Ther. 2024. PMID: 39013849 Free PMC article. Review.
Rare Diseases Related with Lipoprotein Metabolism.
Zhou H, Gong Y, Wu Q, Ye X, Yu B, Lu C, Jiang W, Ye J, Fu Z. Zhou H, et al. Adv Exp Med Biol. 2020;1276:171-188. doi: 10.1007/978-981-15-6082-8_11. Adv Exp Med Biol. 2020. PMID: 32705600 Review.
34,525 results
You have reached the last available page of results. Please see the User Guide for more information.